The PRELUDE BTK Study

NCT03693963 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease
Critical Limb Ischemia

Interventions

DEVICE: Serranator

Sponsor

Cagent Vascular LLC